Duchenne muscular dystrophy gene therapy ataluren

NICE has published draft guidance for public consultation which does not recommend ataluren (also called Translarna and made by PTC Therapeutics) for treating Duchenne muscular dystrophy (DMD) caused by a nonsense mutation.
Source: NHS Networks - Category: UK Health Source Type: news